Article Sidebar
Article Details
Issue
Section
Articles
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the SA Academy of Family Practice/Primary Care. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
Main Article Content
Audit of failure rate of CoartemTM to treat falciparum malaria at single fourteen-day follow-up
Abstract
Objective. To assess the failure rate of the new first line treatment regime for uncomplicated falciparum malaria in KwaZulu-Natal of CoartemTM tablets (20mg artemether and 120mg lumefantrine Novartis South Africa (PTY) Ltd). Design. A before-after study1. Setting. Ndumo Clinic, Ingwavuma District, KwaZulu-Natal, South Africa, February 2001. Study Group. 67 patients presenting to Ndumo clinic with uncomplicated malaria. diagnosed by symptoms and positive immunochromographic test for plasmodium falciparum. Main outcome measures. Trophozoite count on thick film at day 14. Results. All of the 58 follow-up slides obtained were negative. 8 patients failed to return, and 1 slide washed off. Only 43 smears were positive at day 0 of which 36 had follow-up smears. Conclusions. No resistance to CoartemTM was shown at day 14, and CoartemTM has been shown to be more effective at clearing falciparum malaria parasites than a previous regime of sulfadoxine/pyrimethamine with chloroquine.
Keywords: Falciparum malaria, artemether,Lumefantrine
SA Fam Prac Vol.25(3) 2002: 8-12
Keywords: Falciparum malaria, artemether,Lumefantrine
SA Fam Prac Vol.25(3) 2002: 8-12
